EP0922760A3 - Animal transgénique n' exprimant pas de facteur inhibant l'ostéoclastogenèse (OCIF) endogène - Google Patents

Animal transgénique n' exprimant pas de facteur inhibant l'ostéoclastogenèse (OCIF) endogène Download PDF

Info

Publication number
EP0922760A3
EP0922760A3 EP98122542A EP98122542A EP0922760A3 EP 0922760 A3 EP0922760 A3 EP 0922760A3 EP 98122542 A EP98122542 A EP 98122542A EP 98122542 A EP98122542 A EP 98122542A EP 0922760 A3 EP0922760 A3 EP 0922760A3
Authority
EP
European Patent Office
Prior art keywords
inhibitory factor
ocif
transgenic animals
transgenic animal
osteoclastogenesis inhibitory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98122542A
Other languages
German (de)
English (en)
Other versions
EP0922760A2 (fr
Inventor
Atsuko Mizuno
Akihiko Murakami
Nobuaki Fujise
Yasushi Sato
Takeshi Kanno
Eisuke Daia-paresu Tsuda
Tomonori Morinaga
Kanji Higashio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of EP0922760A2 publication Critical patent/EP0922760A2/fr
Publication of EP0922760A3 publication Critical patent/EP0922760A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
EP98122542A 1997-12-02 1998-12-01 Animal transgénique n' exprimant pas de facteur inhibant l'ostéoclastogenèse (OCIF) endogène Withdrawn EP0922760A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9332240A JPH11155420A (ja) 1997-12-02 1997-12-02 トランスジェニック動物
JP33224097 1997-12-02

Publications (2)

Publication Number Publication Date
EP0922760A2 EP0922760A2 (fr) 1999-06-16
EP0922760A3 true EP0922760A3 (fr) 2000-01-12

Family

ID=18252752

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98122542A Withdrawn EP0922760A3 (fr) 1997-12-02 1998-12-01 Animal transgénique n' exprimant pas de facteur inhibant l'ostéoclastogenèse (OCIF) endogène

Country Status (3)

Country Link
EP (1) EP0922760A3 (fr)
JP (1) JPH11155420A (fr)
CA (1) CA2254949A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1377610A2 (fr) 2001-04-03 2004-01-07 Société des Produits Nestlé S.A. Osteoprotegerine dans le lait
JP3949520B2 (ja) 2001-09-20 2007-07-25 独立行政法人科学技術振興機構 レギュカルチン過剰発現モデル動物
JP2006094701A (ja) * 2002-09-17 2006-04-13 Chugai Pharmaceut Co Ltd ７ｆ４遺伝子トランスジェニック動物
JP2005124402A (ja) * 2003-10-21 2005-05-19 Pharmaceuticals & Medical Devices Agency 骨疾患のモデル動物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019166A1 (fr) * 1992-03-23 1993-09-30 The University Of North Carolina At Chapel Hill Petits animaux modeles pour l'etude de metabolisme du cholesterol
WO1996026217A1 (fr) * 1995-02-20 1996-08-29 Snow Brand Milk Products Co., Ltd. Proteine nouvelle et ses procedes de production
WO1997023614A1 (fr) * 1995-12-22 1997-07-03 Amgen Inc. Osteoprotegerine
WO1999019468A1 (fr) * 1997-10-15 1999-04-22 Amgen Inc. Mammiferes a carence d'expression en osteoprotegerine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019166A1 (fr) * 1992-03-23 1993-09-30 The University Of North Carolina At Chapel Hill Petits animaux modeles pour l'etude de metabolisme du cholesterol
WO1996026217A1 (fr) * 1995-02-20 1996-08-29 Snow Brand Milk Products Co., Ltd. Proteine nouvelle et ses procedes de production
EP0816380A1 (fr) * 1995-02-20 1998-01-07 Snow Brand Milk Products Co., Ltd. Proteine nouvelle et ses procedes de production
WO1997023614A1 (fr) * 1995-12-22 1997-07-03 Amgen Inc. Osteoprotegerine
WO1999019468A1 (fr) * 1997-10-15 1999-04-22 Amgen Inc. Mammiferes a carence d'expression en osteoprotegerine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BILEZIKIAN J ET AL (EDITORS): "Principles of Bone Biology - Chapter 86: "Gene Targeting" by Karaplis A.C.", ACADEMIC PRESS INC., 1996, XP002090123 *
BUCAY N ET AL: "Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification", GENES & DEVELOPMENT, vol. 12, no. 9, 1 May 1998 (1998-05-01), pages 1260 - 1268, XP002090118 *
MIZUNO A ET AL: "Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 247, no. 3, 29 June 1998 (1998-06-29), pages 610-615, XP002090119 *

Also Published As

Publication number Publication date
JPH11155420A (ja) 1999-06-15
CA2254949A1 (fr) 1999-06-02
EP0922760A2 (fr) 1999-06-16

Similar Documents

Publication Publication Date Title
EP1120036A3 (fr) Structure comprenant une stalle pour un animal
WO2002085285A3 (fr) Methodes et compositions permettant de reguler la formation osseuse et cartilagineuse
EP0791359A4 (fr) Remede contre des maladies provoquees par la production d'il-6
ZA981937B (en) Prediction of coronary artery disease.
DE69225118D1 (de) Durch Reizung von einem implantierten Skelettmuskelstransplantat arbeitendes Arrhythmiekontrollgerät
AU2002328429A1 (en) CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
WO2005025504A3 (fr) Modulateurs de l'activite de la calcitonine et de l'amyline
GB2319725B (en) Extracting particles produced by the treating of human or animal nails
HU9904387D0 (en) Foot wear for animals, particularly for horses
PT2009025E (pt) Método de inibição da actividade dos osteoclastos
MD990252A (en) Method of controlling the phytopathogenic diseases of grain crops and the fungicidal composition containing 4-phenoxychinoline
WO2002069908A3 (fr) Procedes d'identification de composes permettant de reguler la masse ou la fonction musculaire au moyen de recepteurs de la corticoliberine
PT989973E (pt) Calconas possuindo actividade antiproliferativa
WO2000034511A3 (fr) ANALYSE SELECTIVE DE Aβ-PEPTIDE
EP0922760A3 (fr) Animal transgénique n' exprimant pas de facteur inhibant l'ostéoclastogenèse (OCIF) endogène
HK1039279A1 (zh) 預測和治療腎病及相關疾病的基因和蛋白質
WO1999029308A3 (fr) Procede pour lutter contre l'obesite
WO2000021550A3 (fr) Methodes et compositions de traitement des maladies neurodegeneratives
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
WO1999050671A3 (fr) Proteine toso comme cible de criblage de medicaments
WO2003026404A3 (fr) Disruptions du recepteur de chimiokine ccr6, compositions et methodes correspondantes
WO2000076552A8 (fr) Procedes et compositions pour la regulation de l'osteoformation par modulation de l'activite de la leptine
EP1281963A3 (fr) Procédé de criblage des composés inhibant l'interaction entre des peptides ayant un domaine riche en proline et des peptides comprenant un domaine SH3
EP1211931A4 (fr) Souris knockout pour le gene suppresseur de tumeur anx7
WO2004003507A3 (fr) Procedes d'identification de composes regulant la masse ou la fonction musculaire au moyen de recepteurs de l'amyline

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990226

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): CH DE ES FR GB IT LI NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/00 A, 7A 01K 67/027 B, 7C 07K 14/52 B, 7A 61K 49/00 B

AKX Designation fees paid

Free format text: CH DE ES FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20020528